CorVel Corporation (CRVL) - 10-K Summary
Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2003
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation, group health, and auto insurance. Services include automated medical fee auditing, preferred provider networks (PPO), utilization review, case management, and vocational rehabilitation.
Key Developments: In May 2002, the Company acquired AnciCare PPO, Inc., a provider of diagnostic imaging services, expanding its CorCare PPO network. The Company also continued its stock repurchase program, having repurchased approximately 5.23 million shares (33% of outstanding stock) for $84 million since 1996.
Key Financial Metrics (Fiscal Year 2003)
| Metric | 2003 (in thousands) | 2002 (in thousands) |
|---|---|---|
| Revenues | $282,776 | $235,912 |
| Cost of Revenues | $230,947 | $193,225 |
| Gross Profit | $51,829 | $42,687 |
| Gross Margin | 18.3% | 18.1% |
| Net Income | $16,584 | $14,821 |
| Diluted EPS | $1.50 | $1.30 |
| Cash & Equivalents | $5,913 | $12,601 |
| Working Capital | $37,513 | $35,539 |
| Operating Cash Flow | $22,248 | $27,182 |
Revenue Mix (2003): Provider Program Services (54.5%) and Patient Management Services (45.5%).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 20% to $283 million, driven primarily by a 33% increase in Provider Program Services ($154 million). Approximately 25% of this increase was attributable to the AnciCare acquisition.
- Profitability: Net income rose 12% to $16.6 million. The effective tax rate remained stable at 38.0%.
- Cost Structure: Cost of revenues increased to $231 million but decreased as a percentage of revenue to 81.7% (from 81.9% in 2002) due to the higher mix of lower-cost provider program services.
- Liquidity: Cash and cash equivalents decreased by $6.7 million to $5.9 million. This decline was driven by a decrease in operating cash flow and increased investing activities (acquisition and capital expenditures).
- Accounts Receivable: Net accounts receivable increased significantly from $33 million to $45 million, causing Days Sales Outstanding (DSO) to rise from 50 days to 56 days.
Outlook, Risks, and Management Commentary
Management Commentary: Management attributes growth to increased bill review volumes, PPO network expansion, and the AnciCare acquisition. General and administrative expenses rose to $25.1 million (8.9% of revenue) due to increased MIS staff supporting the "Care MC" electronic data interface capabilities.
Liquidity and Capital Resources: The Company maintains a $5 million line of credit (established April 2003, no borrowings as of filing). Management believes existing cash, operating cash flow, and the credit line are sufficient for the next 12 months.
Risks and Contingencies:
- Regulatory Changes: The business is heavily dependent on state-by-state workers' compensation laws. Changes in legislation or the adoption of managed care organizations (MCOs) by states could impact demand.
- Competition: The industry is fragmented and competitive, with larger insurance carriers and HMOs offering similar services.
- Market Dynamics: Declines in workers' compensation claims or costs in various states could adversely affect revenue.
- Key Personnel: The Company relies on key management and the ability to recruit qualified nurses and healthcare professionals in a tight labor market.
- Technology: Operations depend on proprietary software; system failures or inability to upgrade could materially harm the business.
Investor Verification Checklist
- Accounts Receivable Quality: Verify the trend in Days Sales Outstanding (DSO), which increased to 56 days, and assess the adequacy of the allowance for doubtful accounts ($3.5 million).
- Acquisition Integration: Confirm the financial performance of the AnciCare acquisition and whether it is meeting revenue targets required for contingent purchase price payments.
- Regulatory Exposure: Monitor legislative changes in key states regarding workers' compensation managed care and fee schedules.
- Stock Repurchase Program: Review the remaining authorization under the stock repurchase plan (6.1 million shares authorized; 5.23 million repurchased as of March 31, 2003).
- Goodwill Valuation: Note the adoption of SFAS 142, which stopped goodwill amortization. Review the Company's assessment of goodwill impairment ($8.9 million recorded).